Back to Search Start Over

International Pediatric COVID-19 Severity Over the Course of the Pandemic

Authors :
Zhu, Y
Almeida, FJ
Baillie, JK
Bowen, AC
Britton, PN
Brizuela, ME
Buonsenso, D
Burgner, D
Chew, KY
Chokephaibulkit, K
Cohen, C
Cormier, SA
Crawford, N
Curtis, N
Farias, CGA
Gilks, CF
von Gottberg, A
Hamer, D
Jarovsky, D
Jassat, W
Jesus, AR
Kemp, LS
Khumcha, B
McCallum, G
Miller, JE
Morello, R
Munro, APS
Openshaw, PJM
Padmanabhan, S
Phongsamart, W
Reubenson, G
Ritz, N
Rodrigues, F
Rungmaitree, S
Russell, F
Safadi, MAP
Saner, C
Semple, MG
da Silva, DGBP
de Sousa, LMM
Souza, MDM
Spann, K
Walaza, S
Wolter, N
Xia, Y
Yeoh, DK
Zar, HJ
Zimmermann, P
Short, KR
Zhu, Y
Almeida, FJ
Baillie, JK
Bowen, AC
Britton, PN
Brizuela, ME
Buonsenso, D
Burgner, D
Chew, KY
Chokephaibulkit, K
Cohen, C
Cormier, SA
Crawford, N
Curtis, N
Farias, CGA
Gilks, CF
von Gottberg, A
Hamer, D
Jarovsky, D
Jassat, W
Jesus, AR
Kemp, LS
Khumcha, B
McCallum, G
Miller, JE
Morello, R
Munro, APS
Openshaw, PJM
Padmanabhan, S
Phongsamart, W
Reubenson, G
Ritz, N
Rodrigues, F
Rungmaitree, S
Russell, F
Safadi, MAP
Saner, C
Semple, MG
da Silva, DGBP
de Sousa, LMM
Souza, MDM
Spann, K
Walaza, S
Wolter, N
Xia, Y
Yeoh, DK
Zar, HJ
Zimmermann, P
Short, KR
Publication Year :
2023

Abstract

IMPORTANCE: Multiple SARS-CoV-2 variants have emerged over the COVID-19 pandemic. The implications for COVID-19 severity in children worldwide are unclear. OBJECTIVE: To determine whether the dominant circulating SARS-CoV-2 variants of concern (VOCs) were associated with differences in COVID-19 severity among hospitalized children. DESIGN, SETTING, AND PARTICIPANTS: Clinical data from hospitalized children and adolescents (younger than 18 years) who were SARS-CoV-2 positive were obtained from 9 countries (Australia, Brazil, Italy, Portugal, South Africa, Switzerland, Thailand, UK, and the US) during 3 different time frames. Time frames 1 (T1), 2 (T2), and 3 (T3) were defined to represent periods of dominance by the ancestral virus, pre-Omicron VOCs, and Omicron, respectively. Age groups for analysis were younger than 6 months, 6 months to younger than 5 years, and 5 to younger than 18 years. Children with an incidental positive test result for SARS-CoV-2 were excluded. EXPOSURES: SARS-CoV-2 hospitalization during the stipulated time frame. MAIN OUTCOMES AND MEASURES: The severity of disease was assessed by admission to intensive care unit (ICU), the need for ventilatory support, or oxygen therapy. RESULTS: Among 31 785 hospitalized children and adolescents, the median age was 4 (IQR 1-12) years and 16 639 were male (52.3%). In children younger than 5 years, across successive SARS-CoV-2 waves, there was a reduction in ICU admission (T3 vs T1: risk ratio [RR], 0.56; 95% CI, 0.42-0.75 [younger than 6 months]; RR, 0.61, 95% CI; 0.47-0.79 [6 months to younger than 5 years]), but not ventilatory support or oxygen therapy. In contrast, ICU admission (T3 vs T1: RR, 0.39, 95% CI, 0.32-0.48), ventilatory support (T3 vs T1: RR, 0.37; 95% CI, 0.27-0.51), and oxygen therapy (T3 vs T1: RR, 0.47; 95% CI, 0.32-0.70) decreased across SARS-CoV-2 waves in children 5 years to younger than 18 years old. The results were consistent when data were restricted to unvaccinated children. CONC

Details

Database :
OAIster
Publication Type :
Electronic Resource
Accession number :
edsoai.on1426984653
Document Type :
Electronic Resource